Form 4: Director Tariq Musa Executes Guardant Health Stock Trade

Director Tariq Musa acquired 250 shares of Guardant Health via RSU vesting and sold 116 shares to cover tax obligations.

Summary

• Director Tariq Musa acquired 250 shares of Guardant Health (GH) common stock on April 15, 2026, through the vesting of Restricted Stock Units (RSUs).
• On April 16, 2026, the director sold 116 shares of common stock at a price of $84.83 per share.
• Following these transactions, the director holds 8,528 shares of Guardant Health common stock.
• The transactions were conducted pursuant to a Rule 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is a routine administrative action related to equity compensation vesting and tax coverage.

Positives

• The director maintains a significant equity stake of 8,528 shares in the company.
• The transaction was executed under a pre-arranged Rule 10b5-1 plan, indicating systematic rather than reactive trading.

Negatives

• The sale of shares, even if for tax purposes, reduces the total beneficial ownership of the director.

Risks

• Future share price volatility could impact the value of the director's remaining holdings.

Future Outlook

No specific forward-looking guidance regarding company performance was provided in this filing.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those executed under Rule 10b5-1 plans, are standard corporate governance practices for liquidating equity compensation and do not typically signal a change in management's outlook on the company's fundamental health.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is a standard industry practice for directors to manage personal equity holdings while avoiding potential conflicts with insider trading regulations.

Stakeholder Impact

• Minimal impact on shareholders as the transaction represents a routine adjustment of director equity holdings.

Next Steps

• Continued monitoring of future Form 4 filings for further insider activity.

Key Dates

Keywords

Guardant Health, GH, Insider Trading, Form 4, Tariq Musa, Equity Compensation